Quantcast
Connect with us

Study links Paxil to increased breast cancer risk in women

Published

on

After developing a faster way to identify drugs and chemicals that may disrupt the balance of hormones in the human body, California scientists have fingered the popular anti-depressant drug Paxil and linked it to a possible increased breast cancer risk.

The study, reported by the Los Angeles Times, found that the popular antidepressant Paxil (chemically known as paroxetine) has a weak “estrogenic effect,” meaning that it may be responsible for cancers in some women. They compared it against 445 other drugs “in wide circulation,” according to the report.

ADVERTISEMENT

The particular screening method used to detect hormonal changes after exposure to drugs or chemicals is new. The method also identified two other medications — the antifungals biconazole and oxyconazole — as having an anti-estrogenic effect. This is in opposition to Paxil, meaning it may reduce cancer or the recurrence of cancer in some women. Estrogen is seen playing a role in the growth and recurrence of cancers.

The study builds upon a finding in another Canadian examination of Paxil in 2010. That study found that breast cancer patients who took Paxil were more likely to die of breast cancer if they took it in concert with tamoxifen, an anti-cancer drug.

In the Canadian study, researchers hypothesized that Paxil might block the production of a liver enzyme needed to metabolize tamoxifen.

A 2012 study conducted in Holland also linked Paxil and other selective serotonin reuptake inhibitors (SSRIs) — a popular antidepressant class that includes the drugs Prozac and Zoloft — with increased falls among elderly patients. A 2012 study found Paxil more than doubled the risk of a woman’s child being born with a birth defect that affects breathing.

Writes the Times:

Last summer, the Food and Drug Administration approved the marketing of a low dose of paroxetine — repackaged under the commercial name Brisdelle — as a nonhormonal treatment for hot flashes and other menopausal symptoms.

About 70% of breast cancers in women are sensitive to estrogen, meaning that the hormone found plentifully in females of child-bearing age contributes to their growth.

The novel screening method… described in a forthcoming issue of the journal Toxicological Sciences, also identified two antifungal medications — biconazole and oxyconazole — as having an anti-estrogenic effect similar to that of medications prescribed to prevent breast cancer and its recurrences in women. Incidental to their intended use in combating fungal infections, those medications inhibit the action of aromatase, an enzyme that converts androgens — hormones more plentiful in males but present in both sexes — into estrogen…

Less surprising, the high-throughput screening mechanism identified bisphenol A — a compound used in the manufacture of plastics and epoxy resins — as an estrogen promoter capable of raising breast cancer risk.

ADVERTISEMENT

Paxil has been on the market since 1992. According to the Times, almost a quarter of American women in their 40s and 50s take an antidepressant, generally an SSRI.

[Photo credit: Shutterstock]


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

Here’s why Trump contradicted his own White House on the Supreme Court rulings

Published

on

Following the Supreme Court's pair of 7-2 decisions rejecting President Donald Trump's claim to have absolute immunity from subpoenas, he blasted the ruling on Twitter, claiming he being unfairly targeted and the victim of "prosecutorial misconduct." However, White House Press Secretary Kayleigh McEnany released a statement saying that "President Trump is gratified by today’s decision."

Continue Reading

Breaking Banner

‘They deserve it’: Republican strategist tells GOP it’s their own fault for going down with Trump because ‘they know better’

Published

on

Republican strategist Susan del Percio said that there is no excuse for GOP members who failed to do the right thing and fight back against President Donald Trump when they had the opportunity.

Speaking to MSNBC's Joy Reid Thursday, del Percio called Trump "the anchor" around the GOP's necks, "dragging them down."

"But, you know what, they deserve it," she continued. "There are Republicans out there that deserve this because they know better. They should have been better on impeachment. They should have been holding him accountable all along. Now they are scared and worried about themselves. Well, boohoo, you brought it on. there's no excuse."

Continue Reading
 

Breaking Banner

Trump officials demanded the Army ‘dig for misconduct’ to justify firing Lt. Col. Vindman

Published

on

This week, Lt. Col. Alexander Vindman willingly left the Army after decades of honorable service. He cited a concerted campaign of "bullying" from the highest branches of power in the United States, and now more details are becoming known.

A New Yorker report revealed that top aides to President Donald Trump were told that they needed to find dirt on Vindman that could justify the firing of the decorated war hero.

"Vindman expected to go to the National War College this fall—a low-profile assignment—then take another foreign posting," the New Yorker reported. "But, in a final act of revenge, the White House recently made clear that Trump opposed Vindman’s promotion. Senior Administration officials told [Defense Secretary Mark] Esper and Ryan McCarthy, the Secretary of the Army, to dig for misconduct that would justify blocking Vindman’s promotion. They couldn’t find anything, multiple sources told me. Others in the military chain of command began to warn Vindman that he would never be deployable overseas again—despite his language skills and regional expertise."

Continue Reading
 
 
You need honest news coverage. Help us deliver it. Join Raw Story Investigates for $1. Go ad-free.
close-image